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The use of engineered cardiac tissue for high-throughput drug screening/toxicology assessment remains
largely unexplored. Here we propose a scaffold that mimics aspects of cardiac extracellular matrix while
preserving the contractility of cardiomyocytes. The scaffold is based on a poly(caprolactone) (PCL)
nanoﬁlm with magnetic properties (MNF, standing for magnetic nanoﬁlm) coated with a layer of
piezoelectric (PIEZO) microﬁbers of poly(vinylidene ﬂuorideetriﬂuoroethylene) (MNFþPIEZO). The
nanoﬁlm creates a ﬂexible support for cell contraction and the aligned PIEZO microﬁbers deposited on
top of the nanoﬁlm creates conditions for cell alignment and electrical stimulation of the seeded cells.
Our results indicate that MNFþPIEZO scaffold promotes rat and human cardiac cell attachment and
alignment, maintains the ratio of cell populations overtime, promotes cell-cell communication and
metabolic maturation, and preserves cardiomyocyte (CM) contractility for at least 12 days. The engi-
neered cardiac construct showed high toxicity against doxorubicin, a cardiotoxic molecule, and
responded to compounds that modulate CM contraction such as epinephrine, propranolol and heptanol.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Several scaffolds that mimic the architecture and biophysics of
the myocardium's extracellular matrix (ECM) have been proposed
in the last decade, with the aim of generating engineered cardiac
tissue [1e3]. Most of the cardiac tissue engineering approaches
have used preformed scaffolds based on polymers such as poly(-
glycerol sebacate) [4] and macroporous nanowire electronic scaf-
folds [5], as well as hydrogels, including alginate [6], ﬁbrin [7],
tropoelastin [8] and collagen [9]. These scaffolds have impact in
cardiac cell attachment/alignment, electrical signal propagationLtd. This is an open access article uand cell maturation. Cardiac cells respond to scaffold stiffness and
topographical cues by changing their cytoskeleton andmorphology
[10,11]. Therefore, scaffolds that favor cardiac cell alignment have
been shown to improve cell-cell interaction and tissue cohesion
[11] as well as action potential duration and transient calcium di-
rection [12]. On the other hand, scaffolds that favor electrical signal
propagation between cardiac cells lead to a cardiac tissue construct
that has synchronous contraction and shows high levels of proteins
involved in muscle contraction and electrical coupling [6,13].
Moreover, external electrical ﬁelds applied to scaffolds seeded with
cardiac cells originate tissue constructs with higher maturation
[14,15]. In this case, the number [14] and organization [15] of
mitochondria between myoﬁbrils is higher, however, the cell's
metabolic proﬁle has not been evaluated. Overall, although the
molecular mechanisms behind the inductive properties of scaffoldsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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scaffolds that couple mechanical, anisotropy and electric properties
may foster the development of a functional cardiac tissue [16].
Engineered cardiac tissue may be a relevant platform for car-
diotoxicity and drug screening studies. Cardiotoxicity assessment is
of paramount importance in the development of new drugs. Car-
diac toxicity has been implicated in 28% of drug withdrawals over
the last 30 years [17] and it represents one of the most stringent
exclusion criteria in the licensing process [18]. Although the use of
CMs in a culture dish or within microﬂuidic systems [19] has been
reported, the use of engineered cardiac tissue for automatized
high-throughput drug screening/toxicology assessment remains
largely unexplored. One example has been reported which en-
compasses a miniaturized and automated method based on engi-
neered heart tissue [20]. Unfortunately, more than 20% of the
cardiac cells died over a period of 3 days and the variability in the
force and frequency between cardiac constructs was relatively high.
The development of engineered cardiac tissue for drug screening
requires the creation of scaffolds that are easy to produce and
miniaturize, ﬂexible, and able to preserve the contractility of CMs,
ideally in the absence of an external electrical stimulation since it
will facilitate its implementation in any laboratory.
Here we propose a scaffold that mimics some aspects of cardiac
ECM (Supplementary Fig. 1A) while preserving for at least 12 days
the contractility of fetal rat and human CMs derived from plurip-
otent stem cells. The scaffold is based on a PCL nanoﬁlm (MNF)
coated with PIEZO microﬁbers of poly(vinylidene ﬂuorideetri-
ﬂuoroethylene) (PVDF-TrFE). When a mechanical force is applied to
a piezoelectric material, a change in the polarization density occurs
due to the shifting or rotation of the constitutive dipole crystals. As
a result, a transient electric charge is generated. Therefore, PIEZO
ﬁbers may act as sinoatrial node cells, which in the native tissue are
responsible for cardiac pacemaking [21]. We hypothesize that (i)
the MNF provides a ﬂexible support for cell contraction and (ii) the
aligned PIEZO ﬁbers deposited on top of the MNF create conditions
for cell alignment and electrical stimulation of the seeded cells.
2. Materials and methods
2.1. Preparation and characterization of MNF and MNFþPIEZO
scaffolds
2.1.1. Preparation of MNF and MNFþPIEZO scaffolds
MNFs were prepared by the combined use of a sacriﬁcial layer
and spin coating [22]. Initially, a solution of PVA (1% w/v, in water;
1 mL; Mw ¼ 25.000, 88% hydrolysed; Polysciences, Inc) was added
to the surface of a silicon wafer (400 mm thick, 2  2.5 cm; Pri-
mewafers) and spin-coated (Spincoat G3P-8, Pi-Kem) at 4000 rpm
for 20 s. Then a suspension of superparamagnetic magnetite/
maghemite nanoparticles (10 mg/mL; EMG1300; diameter of
10 nm; FerroTec Co., USA) suspended in a PCL solution (20mg/mL in
chloroform; Mw ¼ 80.000, Aldrich) was added to the wafer and
spin-coated according to the previous spinning parameters. For
MNF experimental group, the polymer-coated wafer was immersed
in water, the PVA sacriﬁcial layer was dissolved, releasing a freely
suspended insoluble nanoﬁlm. For MNFþPIEZO experimental
group, the polymer-coated silicon wafers were ﬁxed to a home-
made rotating collector for the deposition of aligned ﬁbers (rota-
tor motor: Heidolph RZR2020; rotative collector was made as an
aluminium circular frame with the following measurements:
100 mm of diameter, 18 mm of thickness). The ﬁbers were gener-
ated from a solution of poly(vinylidene ﬂuorideetriﬂuoroethylene)
(70:30 w; Solvay) dissolved in methylethylketone (Labor Spirit)
according to a methodology described elsewhere [23]. The pa-
rameters used were: 10e12 kV voltage, 20% (w/v) polymer solutionconcentration, 12 cm tip-to-collector distance, 2 mL/h injection
rate, 40e50% relative humidity at room temperature and 2.000 rpm
collector's rotation speed. The selected collection time was 4 min.
2.1.2. Scaffold characterization: atomic force microscopy (AFM)
analyses
Imaging was performed with a Bruker Innova Scanning Probe
Microscope (Bruker) in dry state, operating in tapping mode, with
oxide-sharpened silicon probes (RTESPA-CP, Veeco Instruments
Inc.) at a resonant frequency of 300 kHz. The sample was scanned
across the edge of the scratch over a 50 mm 50 mm area, recording
128  128 samples. The resulting scan data were elaborated using
the Gwyddion SPM analysis tool (http://gwyddion.net). Scan data
were leveled with the facet level tool to remove sample tilt, and
then the ﬁlm thickness was evaluated as the difference between the
average heights of a region of interest (ROI) selected on the nano-
ﬁlm surface and the average height of the ROI on the silicon wafer.
2.1.3. Scaffold characterization: mechanical tests
Mechanical properties were evaluated bymeasuring their strain
in response to an applied unidirectional stress. An INSTRON 4464
Mechanical Testing System was used, equipped with a ±10 N load
cell. Traction tests were performed on ten samples for each sample
typology. The nanoﬁlms were detached from the substrate, by
immersing them in water, then gently ﬁshed up and allocated be-
tween two aluminium clamps. All specimens were pulled at a
constant speed of 5 mm/min, until reaching sample failure. Data
were recorded at a frequency of 100 Hz. The stress was calculated as
the ratio between the load and the cross-section area of a tensile
specimen, while the strain was calculated as the ratio between its
extension and its initial length. The Young's modulus for each
tested sample was extracted from its stress/strain curve.
2.1.4. Scaffold characterization: scanning electron microscopy
(SEM) analyses
A Phenom Pro tabletop SEM was used for analyses. At least 3
images were taken per each sample. Fiber diameter was deter-
mined by ImageJ software on SEM images. Fiber anisotropy was
determined by a protocol described elsewhere [24] on SEM images.
In this case, the orientation and anisotropy of ﬁbrillar structures in
SEM images was calculated using the image analysis software
ImageJ, where computation on the basis of the gradient of pixel
intensity level is performed over a region of interest in the image.
2.1.5. Scaffold characterization: assessment of impedance and the
direct piezoelectric effect
Scaffold impedance spectra were analyzed by using an impe-
dentiometer (Agilent) in the 40 Hze20 kHz frequency range. The
capacity of piezoelectric microﬁbers to generate charge (direct
piezoelectric effect) was determined using a custom designed
ﬂexible gold electrodes connected to a mix signal oscilloscope
(InﬁiVision, Agilent Technologies). Deformation of the PIEZO
microﬁbers was performed on the surface of two Delrin cylinders
having two different curvatures: curvature I e 84 mm cylinder
diameter; curvature II e 105 mm cylinder diameter. A stack of
PIEZO microﬁbers was prepared (mass of the PVDF-TFRE ﬁber layer
stack ¼ 4.4 mg), and a ﬂexible polyethylene thin-ﬁlm was used as
non-piezoelectric control condition (mass of control thin-
ﬁlm¼ 7.8 mg). The samples were placed in contact with the ﬂexible
gold electrodes. Next, this setup was ﬁxed on cylinders and
manually pressed repeatedly against the cylinder's surface for a
short period of time. Variations of charge generation were regis-
tered during this period. At least 10 replicate measurements were
performed per cylinder. The total voltage generated during each
period of stimulationwas calculated and normalized by the mass of
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2.1.6. Scaffold characterization: piezo-response force microscopy
(PFM) measurements
PFM measurements were performed using a Ntegra Prima
scanning probe microscope (NT-MDT, Russia). All measurements
were done using conductive TiN coated cantilevers NT-MDT
FMG01/TiN (resonance frequency of the used cantilevers was
70e75 kHz). Topography mapping was done in a tapping mode.
PFM was performed in the contact mode by placing a tip at certain
points without scanning. Driving AC voltage with 150 kHz fre-
quency and in the range 1÷10 V (amplitude) was applied to the tip
under ambient conditions. Pt coated Si was inserted between the
ﬁlm and the substrate and served as a grounded bottom electrode.
2.1.7. Scaffold characterization: degradation tests
Samples (average sample area of 4 cm2) were placed in PBS for
12 days at 37 C in the presence of trypsin (20 ng/mL) and colla-
genase type II (350 mg/mL). The enzymatic solution was replaced
each three days by a fresh one. Both enzymes have been used for
heart tissue digestion and isolation of primary cells (see below).
Samples without any treatment (i.e. after preparation) were used as
control. Both samples were washed with PBS, lyophilized and mass
assessed by weighting (and normalized the corresponding initial
area).
2.1.8. Scaffold characterization: ﬁnite element model simulations
FEM simulations were performed with Matlab®R2013a (Math-
Works) and Abaqus 6.13 (Dassault Sys-temes) software's. Matlab
was used to design the system in a parametric way and to manage
data, while Abaqus was used to perform FEM simulations. Simu-
lation conditions for the layer used in the model were retrieved
from experimental data of MN þ PIEZO scaffolds, i.e. thickness of
4.5 mm and an elastic modulus of 5 MPa. Cell related conditions
contained experimental data extracted from ﬂuorescence image
analysis, which provided the total value of 306 cells per area of
layer, and deﬁned the cell dimensions and distribution conﬁgura-
tions. After creating the substrate in the Abaqus environment
(1.4  1.4  0.0045 mm3), by using the Python language, experi-
mental data (stress-strain curves) of the MNFþPIEZO scaffold were
imported by exploiting the Hyperplastic module supported by the
program. In the Abaqus Step module, an explicit dynamic behavior
was deﬁned. Appropriate ﬁxed constraints were applied to the four
membrane edges, thus resembling the real situation (Fig. 1A). A
quad element-based mesh was implemented with 10 mm as char-
acteristic dimension. Cells were modelled with 40  40 mm2
squares, spaced of 40 mm each other and anisotropically oriented
along one preferential direction (data extracted from ﬂuorescence
images of the tissue constructs). Cell contraction force and orien-
tation angle were extracted from literature data, which indicate a
stress of 4 mN/mm2 for primary cardiomyocytes [25] and an angle
of ~20 between focal adhesion average axis and the substrate
plane [26]. Von Mises stresses and overall displacement values
were recorded for each simulation.
2.2. Cell culture in MNF and MNFþPIEZO scaffolds
2.2.1. Isolation and culture of rat fetal CMs
Fetal CMs were obtained from Wistar rat fetus (17e18 days of
gestation) sacriﬁced according to the European Union directives.
After sacriﬁce the hearts were removed, the atria were excised and
the ventricles were placed in Hank's Balanced Salt Solution (HBSS,
pH 7.4, Ca2þ andMg2þ free, Sigma). Next, the ventricles were placed
in a new Petri dish (30e40 per plate) containing a trypsin-EDTA
solution (0.1%, w/v, Gibco) and maintained at 4 C overnight fordigestion. After 18 h, the partially digested tissues were brought to
30-37 C and type II Collagenase (75 U/mL, Worthington
Biochemical Corporation, USA) was added for 30e45 min. The
digested tissue was mechanically dissociated and ﬁltered through a
cell strainer (40 mm, nylon; Falcon). After centrifugation (1200 rpm,
5 min) cells were resuspended in Dulbecco's modiﬁed Eagle's
medium (DMEM) supplemented with 10% (v/v) fetal bovine serum
(FBS), 100 IU mL1 penicillin and 100 mg mL1 streptomycin. Af-
terwards, the cell suspension was then puriﬁed by plating the cells
in a 1% (w/v) gelatin-coated plate for 3 h. The non-adherent cells
were then counted and platted at a density of 450.000 cells per
scaffold (effective area of the scaffold is 0.8 cm2) in DMEM sup-
plemented with 10% (v/v) FBS, 100 IU mL1 penicillin and
100 mg mL1 streptomycin. The average cell yield was of 130  104
per heart.
2.2.2. Differentiation of human induced pluripotent stem cells
(iPSCs) into CM
Human iPSCs DF19-9-11T.H (WiCell, Madison, WI) were
cultured on Matrigel® hESC-Qualiﬁed Matrix (Corning, NY, USA)
coated plates in mTeSR1 medium (StemCell Technologies, Van-
couver, Canada) until reaching 80% conﬂuence. CM differentiation
was induced as described by Lian et al. [27]. At day 15 of differen-
tiation, 2D monolayer cultures composed by 85e99% of hiPSC-CMs
(characterized by the expression of cardiac troponin T and SIRPA
using ﬂow cytometry analysis, as described in section “FACS anal-
ysis”) were obtained. For the experiments with nanoﬁlms, mono-
layer cultures were dissociated into single cells at this time-point,
by incubation with TrypLE™ Select (Thermo Fischer Scientiﬁc) for
5 min, centrifuged (220g, 5 min) and resuspended in standard CM
culture medium (RPMI supplemented with B-27 minus insulin,
both from Thermo Fischer Scientiﬁc).
2.2.3. Phenotype characterization of cardiac cells by FACS analyses
For the experiments with cells of rat origin, cardiac cells after
isolation (see protocol above; 1.25e2.5  105 cells per condition)
were ﬁxed in 4% (v/v) paraformaldehyde (Electron Microscopy
Sciences) solution for 15 min and thenwashed two times with PBS.
Cells were then permeabialized with saponin (0.5%, Sigma) and
labeled with antibodies against cardiac ﬁbroblasts (anti-vimentin,
rabbit, Abcam), CMs (anti-a-actinin, mouse, Sigma) or endothelial
cells (anti-CD31, mouse, ThermoFisher Scientiﬁc). After a washing
step, cells were characterized by a FACS Calibur (BD) and the data
analyzed by a Cell Quest software. Twenty thousand events were
collected in each run. For the experiments with human CMs, after a
5 min dissociation with TypLE™ Select, hiPSC-CMs were washed
twice with PBS and a total of 5  105 cells were incubated with
conjugated antibody SIRPa/b (CD172a/b-PE, BioLegend) or isotype
control IgG1,k-PE (BD Biosciences) for 1 h at 4 C. For analysis of the
expression of cardiac Troponin T, cells were ﬁxed and per-
meabialized with Cytoﬁx/CytoPerm kit (BD Biosciences) according
to the manufacturer's instructions, and incubated with the primary
antibody cardiac Troponin T (Thermo Fischer Scientiﬁc) or isotype
control IgG1 (Santa Cruz Biotechnology) for 1 h at 4 C. Cells were
washed twice with DPBS, and incubated with the secondary anti-
body Alexa Fluor® 488 Goat Anti-Mouse IgG (Thermo Fischer Sci-
entiﬁc). After two washing steps with PBS, cells were analyzed in a
CyFlow® space (Partec GmbH) instrument, registering 10.000
events/sample.
2.2.4. Co-culture of human cells
Normal human dermal ﬁbroblasts (Lonza) were cultured in
DMEM supplemented with 10% (v/v) FBS, 100 IU mL1 penicillin
and 100 mg mL1 streptomycin. After cell conﬂuence, they were
dissociated into single cells by incubation with trypsin-EDTA
Fig. 1. Preparation and characterization of MNF and MNFþPIEZO scaffolds. (A) Scheme showing the methodology used for the preparation of MNF and MNFþPIEZO. Initially, a
sacriﬁcial layer of poly(vinyl alcohol) was deposited in a silicon wafer and spin-coated. This was followed by the spin-coating of a solution of PCL, deposition of PIEZO ﬁbers by
electrospinning, mounting the scaffold in a CellCrown system and culture the cells on top of it. (B)Mechanical properties of MNF and MNFþPIEZO scaffolds obtained by stress-strain
measurements, including elastic modulus (B.1), maximum strain (B.2) and ultimate tensile strength (B.3). The nanoﬁlms were immersed in water to remove them from the silicon
substrate and allow their ﬁxation into the mechanical testing system. Results are Average ± SEM, n ¼ 10. (C) SEM images of the surface of MNF (C.1 and C.2) and MNFþPIEZO (C.3
and C.4). (D) AFM images of MNF and MNFþPIEZO (tapping mode; height imaging). Scan areas of 5050 mm2 were used. Graphs show roughness average (Ra) and root mean
square (RMS) roughness. Results are Average ± SEM, n ¼ 4. (E) Impedance spectra of MNF and MNFþPIEZO scaffolds. The MNFþPIEZO spectrum has two characteristic frequencies
(resonance frequency, fR, and anti-resonance frequency, fA), typically of piezoelectric materials. The MNF spectrum shows no characteristic peaks in the frequency interval tested.
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(1200 rpm, 5 min), ﬁbroblasts were resuspended in RPMI supple-
mented with B-27 minus insulin and seeded with hiPSC-CMs (ratio
of 5:1 CM:Fibroblasts). This co-culture was platted with a cell
density of 600.000 cells per scaffold in RPMI supplemented with B-
27 minus insulin (Thermo Fischer Scientiﬁc).
2.2.5. Coating of the scaffolds for cell culture
The scaffolds were coated with poly(dopamine) and thenwith a
gelatin solution (1%, w/v). The poly(dopamine) coatings wereprepared as described by Haeshin Lee et al. [28]. Brieﬂy, scaffolds
were immersed in a dopamine solution (2 mg of dopamine/HCl per
mL of 10 mM Tris buffer pH 8.5) typically overnight and rinsed with
water for further use. The scaffolds were afterwards mounted in a
CellCrown (Scaffdex Oy, Finland) before cell seeding. Next, the
structures were sterilizedwhile immersed in a disinfection solution
of Penicillin-Streptomycin (1000 U/mL, Life Technologies) and
amphotericin B (Fluka, 10 mg/mL) for 24 h. Afterwards, the nano-
ﬁlms mounted in CellCrowns were exposed to UV light for 30 min
and stored at 4 C. Prior to cell culture, the antibiotics/amphotericin
P.J. Gouveia et al. / Biomaterials 139 (2017) 213e228 217solution was removed and the supports were coated with a 1%
gelatin in solution for 12 h.2.3. Characterization of engineered cardiac tissue
2.3.1. Cell adhesion analyses: DNA extraction and total DNA
quantiﬁcation
DNA samples were obtained from cell extracts with TRIzol Re-
agent (Invitrogen). Extraction was performed accordingly to pro-
tocol described by the manufacturer. Total cell extracts were
divided into 3 different phases containing respectively RNA, DNA
and protein. Quantiﬁcation of each component was performed by
NanoDrop.2.3.2. Cell proliferation and viability tests
For the assessment of cellular proliferation and viability two
different methods were performed: MTT assay (thiazolyl blue
tetrazolium bromide, Sigma) and PrestoBlue (Invitrogen). In case of
MTT assay, the cells were incubated with medium (DMEM, Bio-
chrom) supplementedwithMTT (5mg/mL) for 1 h. Then, cells were
washed with PBS and DMSO was added for 20 min so that the MTT
salts could be solubilized. After a centrifugation step the absor-
bance of the supernatant was read at 540 nm and 620 nm. For the
PrestoBlue, cells were incubated for 2 h and 30 min with a 10%
solution of the reagent andmedium. The resulting supernatant was
diluted (1:1) withmedium and ﬂuorescencemeasured at excitation
535 nm and emission 615 nm.2.3.3. Cell characterization: immunocytochemistry analyses
At speciﬁc time points, cells were ﬁxed in 4% (v/v) para-
formaldehyde for 10 min and permeabialized with 0.1% (v/v) Triton
or with methanol for 10 min when it was recommend by the
antibody supplier. Following the blocking step with 1% (w/v) BSA
for 30 min the cells were incubated with the primary antibody for
1 h at room temperature. The primary antibodies used were: anti-
vimentin (rabbit, Abcam), anti-a-actinin (mouse, Sigma), anti-
connexin 43 (rabbit, Sigma), anti-troponin I (goat, Santa Cruz)
anti-calsequestrin 2 (goat, Santa Cruz), anti-dihydropyridine re-
ceptor alpha-1 (mouse, Thermo Scientiﬁc), hERG (rabbit, Santa
Cruz). After extensive washes with PBS cells were incubated with
the secondary antibody for 30 min at room temperature and
counterstained with DAPI. Cellular alignment was quantiﬁed on
confocal microscopy images taken on samples (63) labeled for a-
actinin (mouse, Sigma; CM population), vimentin (rabbit, Abcam;
CF population) and DAPI (cell nucleus). Each image was processed
according to an analysis protocol described elsewhere [24]. The
orientation and anisotropy of ﬁbrillar structures in raw images was
done using the image analysis software ImageJ, where computation
on the basis of the gradient of pixel intensity level is performed
over a region of interest in the image.
Fluorescence intensity analysis was performed while using
ImageJ image analysis tool set. Brieﬂy, a region of interest (ROI) was
selected by using a drawing/selection tool. Next, measuring settings
“Area”, “Integrated density” and “Mean grey value”were selected at
the “Analyze - Set measurements”menu.Measurements were done
for the ROI and for the respective background levels (3 measure-
ments per image). Afterwards, the measured values were used to
calculate the corrected total cell ﬂuorescence (CTCF) as follows:
CTCF ¼ Integrated Density ðArea of ROI
Mean Fluorescence of backgroundÞ2.3.4. Cell characterization: western blot analyses
Cell protein extracts were diluted in SDS sample buffer (2.5%
SDS, 0.0625 M Tris-HCl, 10% glycerol, 5% 2-mercaptoethanol, 0.05%
bromophenol blue, pH 6.8) and boiled for 5 min at 95 C. Proteins
(30 mg) were separated by SDS/PAGE [10% (v/v)] and transferred
onto PVDF membranes by electroblotting. The membranes were
blocked with 5% skim milk in Tris-buffered Saline-Tween (TBS-T,
20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween 20) and then probed
with an antibody for connexin 43 (produced in rabbit, Sigma), for
troponin I (produced in goat, Santa Cruz) or for a-actinin (produced
in mouse, Sigma). After extensive washings with TBS-T, the blots
were incubated with an alkaline phosphatase-conjugated second-
ary antibody (GE Healthcare, Buckinghamshire, UK). Immunore-
active complexes were detected by chemiﬂuorescence using the
ECF reagent (GE Healthcare). Fluorescence was detected with a
Molecular Imager FX scanner (Biorad). To ensure an equal protein
loading, antibody for CsQ2 (Santa Cruz) was used as internal con-
trol. The intensity of the bands was analyzed using the TotalLab
TL120 software (Nonlinear Dynamics).
2.3.5. Cell characterization: quantitative real-time PCR (qRT-PCR)
analyses
For the in vitro conditions, total RNA was extracted with TRIzol
Reagent (Invitrogen) and immediately stored at 80 C. In the case
of the in vivo rat samples extraction of the RNA samples from the
collected heart tissue was performed with an RNA extraction kit
(Qiagen). In case of human cell experiments, Human Heart Total
RNA (Clontech) extracts were used as reference. RNA was quanti-
ﬁed in a NanoDrop ND-1000 Spectrophotometer (NanoDrop
Technologies, Inc., USA) at 260 nm. The cDNA was reverse tran-
scribed from 1 mg of total RNA, using TaqMan Reverse Transcription
Reagents kit (Invitrogen) according to the manufacturer's in-
structions. The cDNA obtained was stored at 20 C until further
analysis by real time PCR using the ﬂuorescent dye SYBR Green and
the 7500 Fast Real Time PCR System (Applied Byosystems). Speciﬁc
sets of primers were designed by SIGMA (see supplementary
Table 1). Quantiﬁcation of target genes was performed relative to
the reference CsQ2 or TBP (TATA box binding protein). Genes
relative expression ¼ 2[(Ctsample Ctreference)] . The mean minimal
cycle threshold values (Ct) were calculated from quadruplicate
reactions.
2.3.6. Cardiac activity: beating analyses
Videos of the samples were recorded (Camstudio) using a light
microscope at a magniﬁcation of 20. The videos had an average of
300  300 pixels of area. One recording was performed per repli-
cate per experiment. These recording focused on a hot spot, i.e., an
area where synchronous beating was clearly visible. The number of
beatings was obtained by manually counting each beat during the
time-span of the videos. It is important to note that since the res-
olution of the recorded videos was low it was not possible to use
automatic imaging processing methods.
2.3.7. Cardiac activity: live cell Ca2þ analyses
Acquisitions were performed in a Spinning Disc Confocal (Carl
Zeiss). Intracellular Ca2þ transients were quantiﬁed with a Fluo-4
probe (Life Technologies) in cardiac cells cultured in MNFþPIEZO
scaffold for 12days. Firstly, cellswerewashed twicewithHBSSbuffer.
Then, cells were incubated in the dark, at room temperature, for
30e60 min with a loading buffer (PowerLoad™, Probenecid and
probe, Life Technologies). Afterwards, the cellswerewashedwith cell
culturemedia (RPMI supplementedwithB-27minus insulin, Thermo
Fischer Scientiﬁc) and kept in the samemedia during live recording.
In the pharmacological tests the constructs were incubated with
the target compounds for at least 5 min before acquisition.
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frame of the live recording. Fluorescence intensity analysis was
performed with the ImageJ image analysis tool described previ-
ously (see Immunocytochemistry analysis). The function used in
the Ca2þ ﬂux proﬁles was “Plot Z-axis Proﬁle”. Results are shown by
ﬂuorescence intensity as a function of time (acquisitions of 60s,
total of 342 frames). Due to photobleaching decay occurring during
recording, the resulting videos were adjusted by using a custom
ImageJ's macro. Brieﬂy, this macro calculates the decay rate of a
bleached ROI over time and normalizes the ﬂuorescence of each
video frame against the intensity of the previous one. Afterwards,
the values of ﬂuorescence intensity obtained were normalized by
the respective baseline intensity.
A representative video was selected from each tested condition.
The proﬁles for the condition without compounds, with epineph-
rine (Sigma) and with propranolol (propranolol hydrochloride,
Sigma) are the average of 3 independent ROIs from each respective
video recording. The proﬁles for the heptanol condition show the
intracellular Ca2þ ﬂuxes of 3 separated ROIs measured from the
same video acquisition.
2.3.8. Cardiac activity: metabolic proﬁle as evaluated by nuclear
magnetic resonance (NMR)
Rat cells were cultured in Dulbecco's Modiﬁed Eagle's Medium
(D5030, Sigma) supplemented with 4.5 g/L [1,6-13C2]glucose
(Cambridge isotopes), 0.584 g/L L-glutamine (Life Technologies),
3.7 g/L sodium bicarbonate (Sigma) and 10% FBS (Alfagene). Human
cells were cultured in RPMI (without glucose) supplemented with
B-27 minus insulin (both from Thermo Fischer Scientiﬁc) and 2.0 g/
L [1,6-13C2]glucose (Cambridge isotopes). 1H-NMR spectra were
acquired in a 600 MHz Varian VNMRX spectrometer using a 3 mm
broadband NMR probe. Each NMR spectrum consisted of 32k points
covering a sweep width of 7.2 kHz. An interpulse delay of 10 s and a
45 radiofrequency reading pulse were used to ensure full relaxa-
tion of all nuclei in the sample. A total of 16 scans were averaged to
ensure adequate signal to noise for quantitative purposes. Before
Fourier transformation, the free induction decay (FID) was multi-
plied by a 0.2 Hz Lorentzian apodization function. NMR spectra
deconvolution was achieved by NUTSproTM NMR software using
the line-ﬁtting subroutine which allows deconvolution of individ-
ual lines. Each NMR sample consisted of 20 mL culture media plus
200 mL of a 2.5 mM sodium fumarate (internal standard) phosphate
buffered D2O (99.9%) solution.
2.4. In vivo testing
The sub-chronic animal model was performed in Wistar rats (8
weeks old) assigned to 2 groups: DOXO and Vehicle [29]. In this
case, animals were injected subcutaneously weekly in the scruff or
ﬂank with 2 mg/kg DOXO or with equivalent volume of vehicle
solution (0.9% NaCl), during 7 weeks. At the end, animals were
allowed to rest for 2 weeks before being sacriﬁced. Animals were
euthanized by cervical dislocation followed by decapitation, con-
ﬁrming death of the animal. Extraction of the heart with the aortic
stump from the thorax was quickly performed, and heart was
washed in a cold (4 C) Tyrode's buffer to remove blood. For mRNA
analyses, heart tissues were preserved in RNAlater solution
(Ambion, Austin, USA) following the manufacturer's instructions.
2.5. Statistical analyses
An unpaired t-test or one-way ANOVA analyses of variance with
Bonferroni/Newman-Keuls post-tests were performed for statisti-
cal tests using GraphPad Prism. Results were considered signiﬁcant
when P < 0.05.3. Results and discussion
3.1. Preparation and characterization of MNFþPIEZO scaffolds
To prepare the nanoﬁlms, PCL dissolved in chloroformwas spin-
coated on siliconwafers previously coated with a sacriﬁcial layer of
poly(vinyl alcohol) (PVA) (Fig. 1A). Because these nanoﬁlms are
fragile and difﬁcult to manipulate in aqueous solutions, super-
paramagnetic nanoparticles (SPIONs) were added to the PCL solu-
tion before the spin coating as described elsewhere [22]. The
resulting nanoﬁlm has magnetic properties, thus facilitating
manipulation of the nanoﬁlm by using an external magnet (Sup-
plementaryMovie 1), and displays similar mechanical properties to
nanoﬁlms without SPIONs (Supplementary Fig. 1E). We employed
PCL to generate the nanoﬁlms due to its elasticity, biocompatibility,
and a long history in biomedical applications [30]. In addition, it is
expected that the low degradation rate of PCL will not interfere
with the in vitromaintenance of the cardiac tissue (Supplementary
Fig. 1F).
Supplementary data related to this article can be found online at
http://dx.doi.org/10.1016/j.biomaterials.2017.05.048.
For the preparation of nanoﬁlms we screened different con-
centrations of PCL, with the aim of yielding a stable ultrathin
polymeric ﬁlm with low elastic modulus (Supplementary
Fig. 1BeD). After this screening process, we prepared a nanoﬁlm
with an area of 2  2.5 cm2, an approximate average thickness of
229 nm as measured by atomic force microscopy (AFM), an average
surface roughness (Ra) of 0.09 ± 0.03 mm as measured by AFM and
an elastic modulus of 0.06 ± 0.04 MPa as evaluated by traction test
(Fig. 1B.1). The resulting free-standing nanoﬁlm is brownish (due to
the presence of SPIONs), very ﬂexible and can be manipulated with
tweezers or by using a magnet (Supplementary Fig. 1B).
To prepare PIEZOmicroﬁbers, a solution of PVDF-TrFE (20%, w/v)
was electrospun. This copolymer was chosen because it has
enhanced spontaneous dipolar orientation after electrospinning
[31] and it has excellent biocompatibility properties [32,33]. Elec-
trospinning conditions were optimized to generate ﬁbers with
relatively low diameter and high anisotropy after deposition onto
the MNF (scaffold named as MNFþPIEZO) (Supplementary Fig. 2).
In the tested conditions (Fig. 1C and D and Supplementary Fig. 2B),
porous ﬁbers with a diameter of 1.24 ± 0.13 mm (average ± SEM,
n ¼ 3) were obtained. These ﬁbers have piezoelectric properties as
determined by piezo-response force microscopy (PFM), a local
probe-based technique for non-destructive high-resolution piezo-
electric domain imaging and manipulation [34]. Following the
topography acquisition in tapping mode, the AFM was switched to
the PFM inwhich the conducting tip was scanning in contact mode
while an ac voltage (Vac) was applied between the tip and Au
electrode (Fig. 2A.1 and A.2). Over different points of the ﬁbers, the
surface amplitude of the piezo-response varied between 3.5
(d33(min)) and 11.1 p.m./V (d33(max)) (Fig. 2A.3).
The MNFþPIEZO scaffold showed an average surface roughness
(Ra) of 1.30 ± 0.06 mm as measured by AFM (Fig. 1D) and an elastic
modulus of 5.08 ± 0.82 MPa (average ± SEM, n ¼ 3) as measured by
tensile tests (Fig. 1B and Supplementary Fig. 1E), showing that the
presence of the PIEZO ﬁbers led to mechanically stronger con-
structs than MNF alone. Impedance measurements were also per-
formed to evaluate both the piezoelectric and conductive
properties of the constructs. The results demonstrate that the MNF
scaffold has stable impedance values for all frequencies, while
MNFþPIEZO scaffold shows a spectrum with two peaks, a reso-
nance (fR) and an anti-resonance frequency (fA) (Fig. 1E), typical of
piezoelectric materials [35]. To further evaluate the charge gener-
ation capability by the piezoelectric ﬁbers, mechanical deformation
tests were performed (Fig. 2B.1). Measurements were
Fig. 2. Piezoelectric properties of PIEZO ﬁbers and MNFþPIEZO scaffolds. (A) Assessment of piezoelectric properties of PIEZO microﬁbers by PFM. (A.1) AFM images of the PIEZO
microﬁbers. (A.2) Procedure for the determination of piezoelectric properties. (A.3) Amplitude of displacement as a function of AC voltage applied to the samples. The determined
piezoelectric charge constant, d, refers to the induced strain in direction 3 per unit electric ﬁeld applied in direction 3 (d33). Results are Average ± SEM, n ¼ 5. (B)Methodology for
the assessment of the piezoelectric properties in the PIEZO microﬁbers (B.1). Assessment of the direct piezoelectric effect in PIEZO microﬁbers (B.2). PIEZO microﬁbers were
submitted to mechanical deformations at two different curvature values (curvature I refers to the substrate deformed over the external surface of a Delrin cylinder showing a
diameter of 84 mm; curvature II refers to the substrate deformed over the external surface of a Delrin cylinder showing a diameter of 105 mm), while registering the amount of
voltage generated over time (values normalized towards control; Average ¼ 0.00263 mV/s). Results are Average ± SEM, n ¼ 10. * Denotes statistical signiﬁcance: **P < 0.01.
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coupled to a mix signal oscilloscope. Deformation of the PIEZO ﬁber
layers was achieved by bending the substrates over the surface of
Delrin cylinders featured by two different diameters, thus obtain-
ing two different substrate deformation curvatures (curvature I e
cylinders with an 84 mm diameter; curvature II e cylinders with a
105 mm diameter) (Fig. 2B2). We registered a 2-fold increase (from
11.4mV/s to 26.7mV/s) of the charge generatedwith the increase of
the deformation curvature.3.2. MNFþPIEZO scaffolds enhance rat cardiac cell stratiﬁcation
and alignment
To evaluate the in vitro biocompatibility of the scaffold, primary
prenatal rat cardiac cells (59.5 ± 2.9%, CM; 32.1 ± 2.4% cardiac ﬁ-
broblasts (CF) and 5.1 ± 4.7% endothelial cells; Supplementary
Fig. 3A) were seeded on top of the scaffolds and cultured for 12
days. We have selected prenatal rat cardiac cells for the initial
screening because (i) these cells have been used in studies for
cardiac scaffold design [36], (ii) their immature stage in terms of
development is important to evaluate CM maturation [37,38] and(iii) it is relatively easy to have these cells in the desired numbers,
while human CMs derived from pluripotent stem cells are costly
andmore difﬁcult to obtain. We selected 12 days for our analyses to
allow the organization of cells in proper constructs, while being
primed by the ECM for a maturation process. This time-point rep-
resents a good compromise in view of a use of this engineered
cardiac tissue for drug screening by pharmaceutical industries.
MNFþPIEZO scaffolds are cardiac cell adhesive and permissive
to cardiac cell proliferation. Cell adhesion evaluated by DNA
quantiﬁcation at day 1 showed that all the substrates have equiv-
alent cardiac cell adhesive properties (Supplementary Fig. 3B).
Because cardiac ﬁbroblasts and endothelial cells may mediate CM
adhesion to the substrate we have isolated CM from the initial
cardiac cells by magnetic cell sorting and perform the same adhe-
sion tests. Again, similar adhesion results for all the substrates were
observed. In addition, cell proliferation evaluated by DNA quanti-
ﬁcation for the ﬁrst 3 days showed that cardiac cells proliferate in
the scaffolds and the proliferation rate was higher for cells seeded
in MNF or MNFþPIEZO scaffolds than in tissue culture poly(-
styrene) (PS). Moreover, MTT results showed that cells proliferated
from day 1 to day 12 (Fig. 3A).
Fig. 3. Viability, composition and alignment of rat prenatal cardiac cells cultured in different scaffolds. (A) Cell viability/proliferation as assessed by a MTT assay. Results are
Average ± SEM, n ¼ 6. (B) Quantiﬁcation of CM and CF total population per culture area (0.8 cm2) done by confocal microscopy with in immunostained samples (objective 63).
Results are Average ± SEM, n ¼ 3 (three independent experiments; each experiment having at least 3 technical replicas). (C) CM and CF sub-population alignment index in different
substrates. The alignment was calculated through confocal microscopy images (63) of immunostained samples. CM and CF sub-population alignment index in different substrates.
The alignment was calculated in confocal microscopy images (63) of immunostained samples. Cellular alignment was quantiﬁed by taking account the deviation (20 degrees)
towards a common reference line. CM population was identiﬁed as positive for a-actinin staining while CF population was identiﬁed as positive for vimentin. Results are Average ±
SEM, n ¼ 3 (three independent experiments; each experiment having at least 3 technical replicas). (D) Representative confocal microscopy images of cardiac cells cultured in the
different substrates tested for 1 day (T1) and 12 days after seeding (T12). Cells were stained for sarcomeric a-actinin. Scale bar represents 20 mm. (E) Representative confocal images
of positive sarcomeric a-actinin and troponin I CMs cultured under different substrates at T1 and T12. In A and C.1, * denotes statistical signiﬁcance: *P < 0.05, **P < 0.01, ***P < 0.001,
****P < 0.0001.
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altered over time. CMs and CFs were identiﬁed by the expression of
a-actinin and vimentin, respectively (Fig. 3B). At day 1, approxi-
mately 75% of the cells were CM and only 25% were CF (slight
variations in this ratio were observed between the different
experimental conditions). This cell ratio was not statistically
different at day 12. Altogether, our results show that MNFþPIEZO
scaffolds support cell adhesion and proliferation and maintain the
CM/CF ratio from day 1 to day 12. These results compare favorably
to previous studies showing a detrimental decrease in CM popu-
lation overtime when cultured in different scaffolds [39,40].
MNFþPIEZO scaffolds but not MNF or PS enhanced cellular
stratiﬁcation. At day 12 (T12), CMs were located in the proximity ofthe ﬁbers of the MNFþPIEZO scaffold, while CFs were located on
top of CMs and therefore distant from the PIEZO ﬁbers
(Supplementary Fig. 4). It has been shown that cells respond
differently to the microtopography [41] and stiffness [42] of the
substrates. An attractive possibility is that this stratiﬁcation is
linked to the piezoelectric properties of the ﬁbers. Indeed, their
capacity to generate electrical charge may constitute a source of
tropism for CMs.
Previous studies have shown that cell alignment is of utmost
importance to generate contractile cardiac-like tissue. For example,
CM aligned by the use of micro- and nanopatterned biomaterials
show higher action potential conduction velocity and express
higher levels of cell-cell coupling proteins such as Cx43, in
P.J. Gouveia et al. / Biomaterials 139 (2017) 213e228 221comparisonwith randomly oriented CM [8,11]. To evaluatewhether
MNFþPIEZO scaffolds enhanced cell alignment, the local cell
alignment index was quantiﬁed by image analysis. For this purpose
a-actinin and vimentin ﬁlament orientation was identiﬁed and
analyzed for CM and CF populations, respectively (Fig. 3C.1 and C.2).
On MNFþPIEZO scaffolds, CMs showed a 3-fold increase in align-
ment at day 12 as compared to day 1, while no signiﬁcant alignment
was observed for the other conditions (PS andMNF scaffolds) at the
same time-point. CMs aligned with respect to the ﬁbers as shown
by a clear orientation of the sarcomeric a-actinin ﬁbers along the
main PIEZO ﬁbers axis. This clearly suggests a positive impact of
topography on cellular organization (Fig. 3C.1, D and E). Regarding
the CF population, cell alignment was poor in all conditions
(Fig. 3C.2). Overall, MNFþPIEZO scaffolds enhanced rat CM but not
CF alignment. Selective CM alignment might be ascribed to the
stratiﬁcation effect described above, i.e., to the proximity of CMs to
the piezoelectric ﬁbers. Although cell alignment on ultrathin
polymeric ﬁlms has been reported recently on poly(styrene) [43]
and poly(lactic-co-glycolic acid) [44] nanoﬁlms, this was achieved
by the use of a poly(dimethylsiloxane) mold with microgrooved
motifs. Furthermore, anisotropic cell organization has been also
obtained by means of electrospun ﬁbers alone [45,46]. Our study is
the ﬁrst to report the use of electrospun microﬁbers on top of
ﬂexible nanoﬁlms to control cell alignment.
3.3. MNFþPIEZO scaffolds enhance cell-cell communication and
preserve CM contractility
The impact of MNFþPIEZO scaffolds in cardiac cell physiology
was evaluated. For that purpose, rat prenatal cardiac cells cultured
in MNFþPIEZO for 12 days was evaluated by western blot analysis
for sarcomeric a-actinin, troponin I and connexin 43 (Cx43)
[13,15,39]. The band corresponding to the phosphorylated Cx43
(pCx43), and thus active form of the protein [47,48], was quantiﬁed
and normalized by total Cx43 levels. Our results show that the ratio
pCx43/totalCx43 was statistically higher (P < 0.05) on CMs cultured
on MNF or MNFþPIEZO scaffolds than on PS at day 12 (T12)
(Fig. 4A). Cx43 has been shown to regulate cell-cell communication
and to promote a contractile phenotype in CM [49]. The increased
expression of the active form of Cx43 (pCx43) in CMs seeded on
both MNF and MNFþPIEZO scaffolds indicates that both scaffolds
promote cell-cell interaction. We complement the previous west-
ern blot analyses with immunostaining to evaluate the location of
Cx43 (total Cx43) in the engineered cardiac tissue (Supplementary
Fig. 5). For all the conditions tested, Cx43 was located in cell-cell
contact regions. In case of cardiac cells cultured in MNFþPIEZO
scaffold the pericellular location of Cx43 in CMs followed, in many
cases, the alignment of PIEZO microﬁbers.
To further characterize the phenotype of CMs, both sarcomeric
a-actinin and troponin I protein amount was assessed by western
blot and normalized by the expression of calsequestrin 2 (CSQ2), a
CM speciﬁc protein [39]. No changes in sarcomeric a-actinin were
observed for all the experimental conditions tested (Fig. 4B). An
increase in troponin I was observed for cells cultured in
MNFþPIEZO, although no statistical signiﬁcant difference (P > 0.05)
was observed between the conditions tested (Fig. 4C). It is possible
that in both cases (a-actinin and troponin I) the variation occurs in
the phosphorylated forms of the proteins but not in the total levels
of the proteins. For example, it is known that the phosphorylation
levels of troponin I regulates its activity [50]. Moreover, previous
studies have shown that contractile CMs cultured in 3D scaffolds for
12 days have similar levels of a-actinin expression to day zero [20].
Then we sought to evaluate whether MNFþPIEZO scaffolds
could preserve CM contractility overtime. The frequency ofheartbeats in rats is around 360 beats per min (i.e., 6 Hz) [51].
Therefore, we evaluated the number of spontaneous synchronous
beatings per minute in CMs at day 1 and 12 post-cell seeding
(Fig. 4D). While the average rate of beats on cells cultured in PS and
MNF scaffolds did not vary from day 1 to day 12, a signiﬁcant in-
crease in the beating frequency was observed for cells cultured in
MNFþPIEZO scaffolds (from 18 to 119 beats/min). This indicates
that MNFþPIEZO scaffolds provided a better environment to pre-
serve the spontaneous contractility of CMs than the other experi-
mental groups. Therefore, for the subsequent experiments we
focused on MNFþPIEZO scaffolds, with the aim of deeply charac-
terizing the cell-scaffold interaction mechanisms.
To understand whether the observed contractility preservation
was due to the piezoelectric properties of the ﬁbers, we prepared
another MNF scaffold having on top aligned PCL ﬁbers (MNFþPCL),
as non-electroactive substitutes of the PIEZO ones (Supplementary
Fig. 6). The PCL ﬁber-based scaffold ability to maintain CM
contractility was signiﬁcantly lower than the PIEZO ﬁber-based
scaffold. In line with these results, cardiac cells cultured in PCL
ﬁber-based scaffolds showed lower levels of Cx43 mRNA tran-
scripts, and thus lower intercellular communication, than cells
cultured in PIEZO ﬁber-based scaffold (Supplementary Fig. 6E.1).
The high beating rates observed in cells cultured in MNFþPIEZO
scaffolds are likely due to the positive effect of the electrically
charged environment generated by the PIEZO ﬁbers during cell
contraction. Thus, to conﬁrm this hypothesis, ﬁnite element model
(FEM) simulations were performed to show that the MNFþPIEZO
scaffold did undergo a signiﬁcant deformation during CMs beating.
Local stresses up to ~0.5 MPa (Supplementary Fig. 7B.1 and B.2) and
displacement values up to ~0.2 mm (Supplementary Fig. 7B.3) have
been registered. In addition, we have quantiﬁed the expression
levels of mRNA transcript for the gene Adss1, which encodes a
muscle-speciﬁc isoform of adenylosuccinate synthetase. It has been
demonstrated that this gene is activated once CMs are electrically
paced [52]. The MNFþPIEZO condition showed expression levels
nearly 10 times greater than the MNFþPCL condition
(Supplementary Fig. 6E.2) and thus showing a charge effect of
piezoelectric ﬁbers on CMs.
Altogether, the high levels of Cx43 phosphorylation indicate
that cells cultured in MNFþPIEZO scaffolds have increased cell-cell
communication, likely inﬂuencing electrical coupling and pro-
moting contractile behavior, as compared to CMs cultured in PS.
Similar results have been previously reported for cardiac tissues
cultured under electrical stimulation or conductive scaffolds
[6,13,15]. Our results further show a discrete increase in the
expression of markers related to contractile cellular apparatus such
as troponin I. Notably, the contraction frequency observed in CMs
seeded on MNFþPIEZO is higher than the one observed for other
constructs such as scaffolds formed by elastin (ca. 40 beats min1,
day 12) [8], methacrylated gelatin (ca. 20 beats min1, day 12) [8],
methacrylated gelatin containing carbon nanotubes (ca.
45 beats min1, day 9) [53] and Matrigel with ﬁbrin (ca.
70 beats min1, day 15; average of 6 series) [20]. Furthermore, pre-
natal rat CMs cultured in MNFþPIEZO exhibit an increase in the
contraction frequency overtime while cells cultured in hyaluronic
acid patterned glass surfaces or Matrigel exhibit a decrease in their
contraction frequency within 7 days of culture [54,55]. It is likely
that the enhanced contractility of the cardiac cells in MNFþPIEZO
scaffolds is due to electric charge generated during CM contraction.
During CM contraction action potential signal varies approximately
100 mV [56]. Considering the PIEZO microﬁber properties, we
propose that the electrical stimuli provided by PIEZO microﬁbers
(~10e30mV) is generated in the proximity of CMs, allowing a direct
and efﬁcient stimulation.
Fig. 4. Contraction and expression of sarcomeric (a-actinin, troponin I) and gap junction connexin 43 proteins of rat prenatal cardiac cells cultured in different scaffolds.
(A) Ratio of phosphorylated versus total connexin 43, at day 1 and 12 of culture (n ¼ 3, 3 replicas at minimum). (B) Sarcomeric a-actinin expression at 1 and 12 days of culture (n ¼ 3,
3 replicas at minimum) normalized to the expression of calsequestrin 2 (CSQ2). (C) Troponin I protein levels at T1 and T12 (n ¼ 3, 3 replicas at minimum) normalized to the
expression of CSQ2. (D) Average of spontaneous cardiac tissue beatings per minute (average of 7 independent experiments n ¼ 7, 3 replicates at minimum per experiment). In A, B
and C, representative western blots are shown on top of the graph. In A, B, C and D, results are Average ± SEM. * Denotes statistical signiﬁcance: *P < 0.05, **P < 0.01, ***P < 0.001,
****P < 0.0001.
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CMs derived from iPSCs
We extended the previous studies in rat prenatal CMs to human
CMs derived from iPSCs (hiPSC-CM). hiPSC-CMs were generated
and cultured as reported previously by us [57]. hiPSC-CMs were
seeded onMNFþPIEZO scaffolds or in PS (as control), alone or in co-
culture with human ﬁbroblasts. A ratio of CM:ﬁbroblast 5:1 was
selected based in the CM:mesenchymal ratio present in early stages
of human development (1 month after birth) [58]. In contrast to rat
CMs (see before), human CMs cultured alone in MNFþPIEZO scaf-
folds aggregated into clusters and thus did not form a monolayer of
cells (Supplementary Fig. 8A.1). However, human CMs co-cultured
with ﬁbroblasts in MNFþPIEZO scaffolds adhered well to thescaffold (Fig. 5A.2 and Supplementary Fig. 8A.2 and B) and prolif-
erated overtime (Supplementary Fig. 8B). Importantly, as noted
previously for rat prenatal CMs, human CMs were located in the
proximity of the PIEZO microﬁbers, while ﬁbroblasts were located
on top of CMs and therefore distant from the PIEZO microﬁbers
(Supplementary Movie 2A). Such cellular stratiﬁcation was not
observed in cells cultured in PS substrates. Our results indicate that
human ﬁbroblasts have an essential role in the adhesion and
morphology of CMs seeded on the MNFþPIEZO substrate. It is
known that ﬁbroblasts greatly contribute to production and
enrichment of the ECM environment, which may contribute for CM
adhesion [59]. Because CMmonocultures did not form a monolayer
of cells in MNFþPIEZO scaffold and showed low expression of
troponin T and Cx43 (Fig. 5B) we performed the subsequent
Fig. 5. Expression of Cx43 and proteins of contractile machinery in human cells at day 12. (A) Confocal microscope images of human cardiac cells cultured in PS (A.1) or
MNFþPIEZO (A.2) for 12 days. Images show the expression and localization of total Cx43 and troponin (sub-units I and T) in a co-culture of hiPSC-CM with ﬁbroblasts. Scale bar
represents 20 mm and 5 mm for the low and high magniﬁcation images, respectively. (B) Quantiﬁcation of cell ﬂuorescence for total Cx43 and troponin from confocal microscope
images. Results are Average ± SEM (n ¼ 2, 4 technical replicates for each n). (C) Average of spontaneous beatings per minute in CMs co-cultured with ﬁbroblasts in PS or MNFþPIEZO
scaffold. Average ± SEM (n ¼ 1, 11 replicates for each n). (D) Representative confocal microscopy images of co-culture of hiPSC-CM with ﬁbroblasts on PS or MNFþPIEZO scaffold.
Scale bar represents 20 mm. (E) Alignment index for hiPSC-CMs and ﬁbroblasts cultured in PS or MNFþPIEZO scaffolds. The alignment was calculated in immuno-stained samples
(CMs stained for troponin T; ﬁbroblasts stained for vimentin). Cellular alignment was quantiﬁed by using ImageJ's plugin FibrilTool. In B, C and E, * denotes statistical signiﬁcance:
*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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Supplementary data related to this article can be found online at
http://dx.doi.org/10.1016/j.biomaterials.2017.05.048.
The impact of MNFþPIEZO scaffolds in human cardiac cell
physiology was initially evaluated for the expression of Cx43 pro-
tein (total) and troponin T. CMs co-cultured with ﬁbroblasts in
MNFþPIEZO scaffolds showed a 2-fold increase in the expression of
Cx43 (total) relatively to the cells cultured in PS (Fig. 5B.1). In
addition, CM's cultured in MNFþPIEZO scaffolds expressed 3 times
more troponin T levels than CMs cultured in PS (Fig. 5B.2).
To evaluate whether MNFþPIEZO scaffolds enhanced cellalignment, the local cell alignment index was quantiﬁed by image
analysis [24]. For this purpose, a-actinin and vimentin ﬁlament
orientation was analyzed for CM and ﬁbroblasts populations,
respectively (Fig. 5E). Both cells have higher alignment index in
MNFþPIEZO scaffolds, along the PIEZO microﬁbers, than in PS
substrate.
The average beating rate in humans is 60e70 (1 Hz) [51]. To
evaluate whether MNFþPIEZO scaffolds preserve human CM
contractility, the number of spontaneous synchronous beatings per
minute was monitored at day 1 and 12 post-cell seeding (Fig. 5C).
Although CMs cultured in MNFþPIEZO or PS had a signiﬁcant
Fig. 6. Effect of DOXO in the metabolism of human cardiac cells cultured in MNFþPIEZO scaffolds. (A) Cellular metabolism was evaluated using the carbon tracer [1,6-13C2]
glucose and proton nuclear magnetic resonance spectroscopy (1H-NMR). Schematic representation of the metabolic ﬂuxes: F1-glucose consumption; F2-lactic acid fermentation;
F3-pyruvate transamination; F4-pyruvate oxidation; F5-pyruvate carboxylation. Through glycolysis, [1,6-13C2]glucose gets converted into two molecules of [3-13C]pyruvate, that can
follow any of the previously mentioned pathways/fates. (B) Human cardiac cells were cultured for 12 days in MNFþPIEZO scaffolds before exposure to DOXO. Cell metabolism was
monitored by NMR. (B.1) Rates of glucose consumption and lactate production in the presence (þ) and absence () of DOXO. (B.2) Ratio of glucose consumption and lactate
production. High ratio's means high oxidative phosphorylation. DOXO treatment causes signiﬁcant increase in glucose consumption in both PS and MNFþPIEZO groups and
promotes an increase in lactate production only in the MNFþPIEZO group. These results suggest that cardiac cells in the PS group are more glycolytic than in the MNFþPIEZO. In B,
results are Average ± SEM, n ¼ 2 (two independent experiments; each experiment having at least 3 technical replicates). *Denotes statistical signiﬁcance: *P < 0.05, **P < 0.01,
***P < 0.001 (unpaired t-test between experimental groups).
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lower in cells cultured inMNFþPIEZO than in PS. This indicates that
MNFþPIEZO scaffolds provided a better environment to preserve
the spontaneous contractility of CMs than PS.
To complement the previous contractility studies, we evaluated
by qRT-PCR 4 of the most relevant ion channel subunits in
mammalian CM electrophysiology [48]: CACNA1C, SCN5A, KCNQ1
and KCNH2 (Supplementary Fig. 9). Human cells cultured on
MNFþPIEZO showed higher content of 2 ion channel subunits
(transcripts SCN5A and KCNH2) than cells cultured on PS (in rat, all 4
ion channel subunits were upregulated in MNFþPIEZO than in PS).
SCN5A encodes an alpha subunit of voltage-gated Naþ channel
while KCNH2 transcripts encode a voltage-activated potassium
channel (hERG). Both ion channel subunits participate at different
stages of action potential [60].
Altogether, our results show that cardiac cells cultured in
MNFþPIEZO scaffold have higher expression of Cx43 (total) and
troponin proteins, higher cell alignment, higher contractility for at
least 12 days, and higher expression of some ion channel subunits
than cardiac cells cultured in PS substrate.3.5. Engineered human cardiac tissue in MNFþPIEZO scaffolds
respond to cardiotoxic compounds
During early cardiac development, glycolysis is a major source
(80%) of energy. However, as CMs mature, mitochondrial oxidative
capacity increases and fatty acid b-oxidation (80%) becomes the
major source of energy [61]. To complement the previous func-
tional and physiological studies, we evaluated the metabolic proﬁle
of cells cultured in PS and MNFþPIEZO scaffolds for 12 days by
nuclear magnetic resonance (NMR). Cardiac cells in MNFþPIEZO or
PS were cultured for 24 h in media containing [1,6-13C2] glucose
and their metabolic proﬁles followed by [1,6-13C2] glucose con-
sumption and [3e13C] lactate production (Supplementary Fig. 10A
and Fig. 6A). The ratio of glucose consumed per lactate produced
is statistically higher for cells cultured inMNFþPIEZO scaffolds than
in PS or MNFþPCL scaffolds indicating a higher oxidative metabolic
activity, and thus a metabolic maturation process (Fig. 6B and
Supplementary Fig. 6F). Previous studies with engineered cardiac
tissues have shown an increase in the number of mitochondria in
more mature CMs [14], however, as far as we know, metabolic
P.J. Gouveia et al. / Biomaterials 139 (2017) 213e228 225studies in engineered cardiac tissues were never reported.
Next, we assessed the potential of the engineered cardiac tissue
inMNFþPIEZO scaffolds to respond to cardiotoxic compounds. The
drugmodel used was doxorubicin (DOXO), often used in the clinics
to treat patients with leukemia and solid tumors. The cardiotoxic
effects of DOXO have been widely reported, with mitochondria as
primary target [62,63]. DOXO impairs mitochondrial oxidative
metabolism and thus cells rely on glycolysis to generate ATP. Cells
cultured in MNFþPIEZO and PS for 12 days were pulsed with
500 nM of DOXO for 24 h. This concentration of DOXO is in the
range of concentrations typically used in the clinic [64]. Cells were
then characterized for viability and transcripts of genes related to
stress responses (BAX, GADD45) (Supplementary Fig. 11). Our re-
sults show that cells cultured in MNFþPIEZO scaffolds for 12 days
are more sensitive to the effect of DOXO than cells cultured in PS
for the same time, since nearly 37% versus 16% of the cells died
after 24 h of exposure to DOXO, respectively (Supplementary
Fig. 11A). As expected for a cell damage process, cardiac cells
cultured in MNFþPIEZO or PS showed an up-regulation in the
expression of BAX and GADD45 after exposure to DOXO
(Supplementary Fig. 11B). Similar results were observed with rat
cardiac cells cultured in MNFþPIEZO or PS and in cardiac cells
isolated from hearts of rats that received multiple doses of DOXO
over 7 weeks (see Supplementary Information and Materials and
Methods for details) (Supplementary Fig. 11C and D). Importantly,
as observed with rat cardiac cells (Supplementary Fig. 10B), the
metabolic proﬁle of human cardiac cells cultured in MNFþPIEZO
became more glycolytic after exposure to DOXO, while cells
cultured in PS had similar levels of glycolysis before and after
exposure to DOXO (Fig. 6B.2). The increase of glycolysis on cells
cultured in MNFþPIEZO is consistent with mitochondrial
dysfunction elicited by DOXO. Exposure to DOXO leads to an in-
hibition of mitochondrial oxidative metabolism, which is likely to
be compensated by glycolysis.
Overall, our viability and metabolic proﬁling results indicate
that engineered cardiac tissues in MNFþPIEZO scaffolds respond to
cardiotoxic compounds to a level that is not possible to achieve
using cells cultured in regular conditions (in this case cultured in
PS). The higher sensitivity of our engineered cardiac tissue is likely
due to a more active mitochondrial function and metabolic matu-
ration. Although a previous study has demonstrated the usefulness
of engineered cardiac tissues to screen cardiotoxic compounds, the
readout was based on the contraction of the cell construct [20],
which might not be as sensitive as the metabolism component
selected in this work. The impact of electric stimulation observed in
cardiac cells cultured in MNFþPIEZO scaffolds is equivalent to re-
sults previously observed for CMs stimulated with external electric
stimuli but using, in most cases, other biomarkers. Previous studies
have shown that external electric current could trigger CM matu-
ration, as demonstrated by shifts in gene expression proﬁle
[65e67], formation of extensive and organized myoﬁbrils [65],
increased levels of structural/contractile proteins [15], enlargement
of CM cell body [65], enhanced intercellular coupling, better ul-
trastructural organization and alignment [15,68]. Overall, the
scaffold proposed here shows high potential to engineer cardiac
tissue relevant for the in vitro screening of drugs.3.6. Engineered human cardiac tissue in MNFþPIEZO scaffolds
respond to compounds that modulate CM contraction
We then sought to investigate the response proﬁle of the
engineered human cardiac tissue to adrenergic receptor modula-
tors (agonist: epinephrine; antagonist: propranolol) and blockers ofintercellular communication (heptanol) (Fig. 7A). Therefore, cells
cultured in MNFþPIEZO and PS for 12 days were loaded with a
calcium-sensitive probe (Fluo-4), to monitor the mobilization of
Ca2þ during cell contraction, and then exposed to a speciﬁc phar-
macologic agent. The concentrations tested were in the range re-
ported by other studies to be non-cytotoxic [69e71].
Norepinephrine activates adrenergic receptors, which induces the
permeability of Ca2þ channels at the cell membrane and sarco-
plasmic reticulum, which in turn leads to an increase of intracel-
lular Ca2þ concentration. Our results show that cardiac cells
cultured in PS substrates have statistically lower beat frequency
relatively to cells cultured in MNFþPIEZO, either in the absence or
presence of norepinephrine (Fig. 7B and C).
Engineered human cardiac tissue in MNFþPIEZO scaffold was
also evaluated in the presence of a b-blocker, propranolol. The high
frequency of beatings induced by epinephrine was blocked by
propanolol (2 mM) (Fig. 7D) but recovered after removing themedia
supplemented with propanolol with basal media (data not shown).
We complemented these analyses by exposing the engineered
human cardiac tissue to a cell-to-cell uncoupler, heptanol [69]. Low
concentrations of heptanol (40 mM) reduced the propagation of
action potential in the CMs analyzed (Fig. 7E) while high concen-
trations of heptanol (250 mM) completely blocked the beating of
CMs. This effect was reversed after the removal of the compound
(data not shown).
Overall, our results show that cardiac cells cultured in
MNFþPIEZO respond to contraction modulators, in the range of
concentrations previously described for human CMs. In addition, in
presence of norepinephrine, CMs cultured in MNFþPIEZO respon-
ded with higher number of beats than cells cultured in PS.4. Conclusions
In conclusion, we have engineered a scaffold that combines
several features to preserve CM contraction overtime and induce
signs of cardiac maturation in cells of rat and human origin. The
scaffold proposed in this work shows unique features
(Supplementary Table 2). Firstly, the integration between a ﬂexible
polymeric matrix and anisotropically aligned piezoelectric ﬁbers,
which induces cell alignment and converts mechanical stress, due
to the CM contraction, in local electrical charges. Secondly, the
whole system can be easily adapted for drug screening tests using
cell metabolism as main readout. The properties of the engineered
cardiac tissue have been compared to other engineered tissues
containing inductive maturation elements (Supplementary
Table 3). Although previous studies have used piezoelectric ﬁbers
with non-contractile cells [23,72], few studies have explored the
effect of piezoelectric materials in contractile cells such as car-
diomyocytes [33,73]. Indeed, the impact of piezoelectric polymers
in human CM's function has not been previously documented. Our
results indicate that MNFþPIEZO scaffold promotes cardiac cell
attachment and alignment, maintains the ratio of cell populations
(CFs:CMs) overtime, promotes cell-cell communication, and pre-
serves CM contractility for at least 12 days. In addition, we have
indications that MNFþPIEZO scaffold promotes CM maturation in
two different cell models as shown by the increase in the expres-
sion of total Cx43 or phosphorylated Cx43, Ca2þ handling proper-
ties, expression of ion channels, metabolic proﬁle, and response to
cardiotoxic compounds that target mitochondria. Overall, the
scaffold proposed here shows high potential to engineer cardiac
tissue relevant for the in vitro screening of drugs. Future studies
should further investigate the effect of piezoelectric materials in
CM function. It is possible that the piezoelectric effect affects
Fig. 7. Live cell imaging of intracellular Ca2þ. A co-culture of hiPSC-CMs with ﬁbroblasts was cultured in MNFþPIEZO scaffolds (for one condition the cells were also cultured in PS
substrate) for 12 days before analysis. Intracellular calcium levels as monitored by using the Fluo-4 Ca2þ sensitive probe. (A) Scheme showing the pharmacological action of the
drugs tested. (B) Effect of norepinephrine (63 mM) in the beating frequency of CMs cultured for 12 days in PS or MNFþPIEZO scaffolds. Results are ± SEM, n ¼ 1 (4e12 ROIs were used
from a representative video recording for the quantiﬁcations). *Denotes statistical signiﬁcance: **P < 0.01, ***P < 0.001, ****P < 0.0001, (unpaired t-test between experimental
groups). (C) Representative traces of intracellular Ca2þ in CMs cultured without drugs (C.1) or with norepinephrine (C.2). (D) Representative traces of intracellular Ca2þ in CMs
cultured with norepinephrine in the presence of increasing concentrations of b-blocker, propranolol. In C and D, Ca2þ proﬁles are the average of 3 ROIs from a representative video
recording. (E) Representative traces of intracellular Ca2þ in CMs cultured with norepinephrine in the presence of gap junction uncoupler heptanol. Each intracellular Ca2þ trace
corresponds to a single ROI obtained from a representative video recording. The three traces indicate an asynchronous beating rate of CMs in which gap junctions have been
disrupted by heptanol.
P.J. Gouveia et al. / Biomaterials 139 (2017) 213e228226cardiomyocyte function/phenotype by interfering with cell mem-
brane potential. In this case, transmembrane ion channels sensitive
to voltage variations might be activated and opened, thus initiating
a process of depolarization of the cellular membrane and conse-
quently cell contraction. It would be interesting to investigate
further intracellular Ca2þ dynamics in cells cultured in piezoelectric
ﬁbers by electrophysiology studies.Acknowledgments
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